期刊文献+

痛风颗粒治疗高尿酸血症痛风的临床体会

Clinical experience of Tongfeng particles treatment of hyperuricemia and gout
下载PDF
导出
摘要 目的:观察痛风颗粒加减治疗高尿酸血症痛风的疗效。方法:将60例高尿酸血症痛风患者随机分为两组,治疗组30例,对照组30例。对照组用秋水仙碱首次1mg,此后每2小时0.5mg,症状缓解后0.5mg/日;别嘌呤醇100mg/日。治疗组在对照组基础上加痛风颗粒(由首乌、白术、土茯苓组成)。两组疗程共4周。观察治疗前后两组血尿酸水平及临床症状变化。结果:所有结果以均值±标准差(x±s)表示,对各项指标之间行t检验,经过4周的治疗,两组的血尿酸比较差异有统计学意义(P<0.01)。结论:痛风颗粒联合秋水仙碱、别嘌呤醇可显著改善痛风患者的临床症状,能显著降低血尿酸水平,疗效优于单独用秋水仙碱及别嘌呤醇。 Objective:To observe the curative effect of Tongfeng particles treatment of gout and hyperuricemia.Methods:60 patients with hyperuricemia and gout patients were randomly divided into two groups,30 cases in the treatment group,30 cases in the control group.Control group was treated with colchicine for 1mg,then 0.5mg every 2 hours,symptoms after 0.5mg/days;fasten purine alcohol 100mg/days.The treatment group in the control group on the basis of ventilation granule(Radix Polygoni Multiflori, Atractylodes,Poria cocos).The two group was treated for 4 weeks.Change in the two groups of serum uric acid levels and clinical symptoms were observed before and after treatment.Results:All results expressed as mean±standard(±S),the indicators for t test, after 4 weeks of treatment,2 groups of patients with significant difference of blood uric acid(P<0.01).Conclusion:Ventilation granule combined with colchicine,fasten purine alcohol can significantly improve the clinical symptoms of the patients with gout, more can reduce the blood uric acid level,curative effect is better than single use of colchicine and fasten purine alcohol.
作者 高玉魁
出处 《中国社区医师(医学专业)》 2014年第9期66-67,共2页
关键词 痛风 痛风颗粒 血尿酸 Gout Air particles The blood uric acid
  • 相关文献

参考文献4

二级参考文献66

  • 1祁开泽,吴涛,柳景红,徐永贵,何科,邓博,沙永新.痛风速效宁对大鼠急性痛风性关节炎的影响[J].湖南中医药大学学报,2006,26(5):27-29. 被引量:4
  • 2徐立,时乐,仲文欣.尿酸酶抑制剂在大鼠急性高尿酸血症模型复制中的应用[J].中国比较医学杂志,2007,17(3):142-146. 被引量:26
  • 3陆渊雷.金匮要略今释[M].北京:人民卫生出版社,1955.1.
  • 4Harris MD, Siegel LB, Alloway JA. Gout and hyperurice-mia[J]. Am Fam Physician, 1999,15:925.
  • 5Terkeltaub R, Zelman D, Scavulli J, et al.Gout Study Gro- up: update on hyperuficemia and gout[J]. Joint Bone Spine, 2009,76(4) : 444.
  • 6Schlesinger N, Schumacher HR Jr. Gout: can management be improved?[J].Curr Opin Rheumatol, 2001,13( 1 ) : 240.
  • 7Ohno K, Tawara K.Pharmacological and clinical profile of rasburicase[J].Folia Pharmacologica Japonica, 2010, 135 (6):255.
  • 8Liu CY, Sims-McCallum RP, Schiffer CA. A single dose of rasburicase is sufficient for the treatment of hyperurice- mia in patients receiving chemotherapy[J]. Leuk Res, 2005 , 29(4) : 463.
  • 9Goldman SC, Holcenberg JS, Finkletstein JZ, et al.A ran- domised comparison between rasburicase and allopurinol in children with lymphoma or leukaemia at high risk for tumour lysis[J].Blood, 2001,97 ( 10 ) : 2 998.
  • 10Pui CH, Jeha S, Irwin D, et a/.Recombinant urate oxi- dase (rasburicase) in the prevention and treatment of ma- lignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate use trial[J]. Leuke- mia,2001, (5):1 505.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部